Localization of Parathyroid Adenoma by Fluorocholine PET/MRI (Positron Emission Tomography -MRI)
Launched by ASSUTA MEDICAL CENTER · Jul 21, 2016
Trial Information
Current as of May 28, 2025
Unknown status
Keywords
ClinConnect Summary
Patients with Hyperthyroidism and surgery indication will be recruited and directed to imagine exams. in addition to the conservative 99mTc-MIBI (methoxyisobutylisonitrile) and US, patients will also undergo 18FCH (¹⁸F-choline) PET/MRI for detecting adenomas and their location. imaging experts will decode the imaging exams. sensitivity and specificity of the exams will be examined.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Patients who meet the criteria accepted in the World Health Organization (WHO) analysis:
- • Symptomatic patients (constipation, depression, peptic ulcer, pathologic fractures, chronic fatigue, pain from a urinary tract stones etc..)
- or at least one of the following criteria:
- • Blood calcium levels above 1 more than normal
- • Creatinine clearance decreased in 30% from age expected
- • Urine Creatinine above 400 mg in 24 hours
- Exclusion Criteria:
- • Patients with hyperthyroidism secondary and tertiary (secondary to kidney disease)
- • Patients who are not eligible to sign an informed consent
- • Pregnant women
- • Patients with sensitivity (allergy) technetium or 18FCH
About Assuta Medical Center
Assuta Medical Center is a leading healthcare institution in Israel, renowned for its commitment to advancing medical research and innovation. As a prominent clinical trial sponsor, Assuta Medical Center facilitates cutting-edge studies across various therapeutic areas, aiming to enhance patient care and treatment outcomes. With a focus on rigorous scientific standards and ethical practices, the center collaborates with multidisciplinary teams of experts to conduct clinical trials that contribute to the development of new therapies and medical technologies. Its state-of-the-art facilities and comprehensive patient network enable Assuta to effectively support diverse clinical research initiatives, ensuring high-quality data collection and analysis.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tel Aviv, , Israel
Patients applied
Trial Officials
Avi hefetz, MD
Principal Investigator
Assuta Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials